Skip to main content
  • 1216 Accesses

Abstract

The superior vena cava syndrome in malignancy is most often secondary to lung cancer where up to 10% of patients with small cell lung cancer and 2% with non-small cell lung cancer will have this syndrome. Classically, steroids, chemotherapy, and radiotherapy have been the standards of therapy. However, over the past few years, stenting has mostly replaced these standards as its advantages are rapid efficacy and giving at least equal results for the clinical syndrome in addition to allowing the securing of a biopsy tissue for diagnosis, and the clinical relief of symptoms is almost immediate.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Dinkel HP, Mettke B, Schmid F et al. Endovascular treatment of malignant superior vena cava syndrome: is bilateral wallstent placement superior to unilateral placement? J Endovasc Ther 2003;10:788–797.

    Article  PubMed  Google Scholar 

  2. De Gregorio Ariza MA, Gamboa P, Gimeno MG et al. Percutaneous treatment of superior vena cava syndrome using metallic stents. Eur Radiol 2003;13:853–862.

    PubMed  Google Scholar 

  3. Rowell NP, Gleeson FV. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus: A systematic review. Clin Oncol 2002;14:338–351.

    Article  CAS  Google Scholar 

  4. Uberoi R. Quality assurance guidelines for superior vena cava stenting in malignant disease. Cardiovasc Intervent Radiol 2006;29:319–322.

    Article  PubMed  Google Scholar 

  5. Nagata T, Makutani S, Uchida H et al. Follow-up results of 71 patients undergoing metallic stent placement for the treatment of malignant obstruction of the superior vena cava. Cardiovasc Intervent Radiol 2007;30:959–967.

    Article  PubMed  Google Scholar 

Suggested Reading

  1. Anaya-Ayala JE, Charlton-Ouw KM, Kaiser CL et al. Successful emergency endovascular treatment for superior vena cava injury. Ann Vasc Surg 2009;23:139–141.

    Article  PubMed  Google Scholar 

  2. Mansour M, Altenburg A, Haage P. Successsful emergency stent implantation for superior vena cava perforation during malignant stenosis venoplasty. Cardiovasc Interv Radiol 2009;32:1312–1316.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mario Dicato .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Society for Imaging Informatics in Medicine

About this chapter

Cite this chapter

Dicato, M., Lens, V. (2010). The Vena Cava Syndrome. In: Olver, I. (eds) The MASCC Textbook of Cancer Supportive Care and Survivorship. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-1225-1_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1225-1_10

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4419-1224-4

  • Online ISBN: 978-1-4419-1225-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics